Research programme: anxiety and epilepsy therapeutics - Bionomics
Latest Information Update: 28 Dec 2021
At a glance
- Originator Bionomics
- Class Antiepileptic drugs; Anxiolytics; Small molecules
- Mechanism of Action G protein-coupled receptor modulators; GABA A receptor agonists; Ion channel modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Anxiety disorders; Epilepsy
Most Recent Events
- 28 Dec 2021 No recent reports of development identified for preclinical development in Anxiety-disorders in Australia (PO)
- 28 Dec 2021 No recent reports of development identified for preclinical development in Epilepsy in Australia (PO)
- 11 Dec 2019 Preclinical development is ongoing in Australia